DexCom Inc.
Sector and Industry
Healthcare, Healthcare Equipment
Performance (1Y)
12.65%
Market Cap
23.31 Bil.
P/E Ratio
31.76
Dividend Yield
0.00 %
Earnings per Share
1.85 €
Peer Group
| Company Name | Market Cap | Revenue Last Reported Year | P/E Ratio | Profit Growth 1Y | Last Price | Previous Trading Day Change |
|---|---|---|---|---|---|---|
| Abbott Laboratories | 185.26 Bil. | 39.29 Bil. | 33.69 | -53.32 % | 0.00 | - |
| Intuitive Surgical Inc | 171.24 Bil. | 8.92 Bil. | 71.93 | +17.90 % | 0.00 | - |
| Boston Scientific Corp | 120.40 Bil. | 17.79 Bil. | 49.17 | +49.88 % | 0.00 | - |
| Stryker Corp. | 114.47 Bil. | 22.26 Bil. | 41.85 | +3.99 % | 0.00 | - |
| Medtronic PLC | 90.93 Bil. | 31.27 Bil. | 22.35 | -4.61 % | 0.00 | - |
| Siemens Healthineers AG | 51.40 Bil. | 23.38 Bil. | 24.04 | +10.40 % | 0.00 | - |
| Hoya Corp | 48.59 Bil. | 5.43 Bil. | 35.69 | +17.33 % | 0.00 | - |
| Becton Dickinson and Co. | 45.46 Bil. | 19.79 Bil. | 32.18 | -3.33 % | 0.00 | - |
| Edwards Lifesciences Corp | 42.15 Bil. | 5.38 Bil. | 47.11 | -27.44 % | 0.00 | - |
| Alcon AG | 33.20 Bil. | 9.24 Bil. | 38.41 | -7.56 % | 0.00 | - |
Facts & figures
Price data
| TRADE PLATFORM | Börse Stuttgart (XSTU) | |
| LAST PRICE | 60.4 G | 0 Units |
| PRICE DETERMINATION TIME | 06/22/2026 / 09:56:53 PM | |
| DAILY VOLUME (UNITS) | 152 | |
| DAILY HIGH / LOW | 63.4 | 60 |
| PREV. DAY'S PRICE | 62.8 | (06/19) |
| CHANGE DAY BEFORE | -2.40 | -3.82 % |
| 52 WEEK HIGH / LOW | 77.36 (07/29) | 47.35 (11/10) |
Key Figures (in EUR)
| 2027e | 2026e | 2025 | 2024 | 2023 | |
|---|---|---|---|---|---|
| EARNINGS PER SHARE | 2.71 | 2.27 | 1.85 | 1.32 | 1.20 |
| DIVIDENDS PER SHARE | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| DIVIDEND YIELD IN % | - | - | 0.00 % | 0.00 % | 0.00 % |
| DIVIDEND GROWTH IN % | - | - | - | - | - |
| PRICE - EARNINGS RATIO | 23.30 | 27.87 | 31.76 | 54.61 | 95.29 |
| PRICE - BOOK RATIO | - | - | 9.30 | 14.45 | 23.12 |
| PRICE - SALES RATIO | - | - | 5.77 | 7.96 | 14.58 |
| PRICE - CASH FLOW RATIO | - | - | 18.68 | 32.44 | 70.54 |
Master Data
| WKN | A0D9T1 |
| ISIN | US2521311074 |
| SYMBOL | DC4 |
| EXCHANGE SEGMENT | Freiverkehr |
| TYPE OF FINANCIAL INSTRUMENT | Equity |
| DENOMINATION | DexCom |
| INDEX MEMBERSHIP | - |
| TRADING SEGMENT | - |
| TRADING HOURS | 07:30:00 AM - 10:00:00 PM |
| TRADING CURRENCY | Euro |
| NOMINAL CURRENCY | US Dollar |
| SETTLEMENT CURRENCY | Euro |
| SECTOR AND INDUSTRY | Healthcare, Healthcare Equipment |
| NUMBER OF SHARES | 385.87 Mil. |
| MARKET CAPITALISATION | 23.31 Bil. |
Performance overview
| 1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | YTD | |
|---|---|---|---|---|---|---|---|---|
| PERFORMANCE | -5.33 % | -2.89 % | 4.73 % | 4.90 % | -12.65 % | -47.60 % | -31.71 % | 5.91 % |
| HIGH | 63.80 | 68.00 | 68.00 | 68.00 | 77.36 | 131.46 | 144.90 | 68.00 |
| LOW | 60.00 | 60.00 | 48.60 | 48.60 | 47.35 | 47.35 | 17.48 | 48.60 |
Dividend
per share
DexCom does not deliver dividend information
Company profile
DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.
Structured products for DexCom Inc.
Analyst Rating
Ø-Target Price DistanceNot Available
Current Price
Not AvailableØ-Target Price
Not AvailableAverage ResultNot Available
Buy0
Overweight0
Hold0
Underweight 0
Sell0
Company Events
No company events available.